Genable Technologies

Genable's GT038 is a gene medicine for treatment of patients with rhodopsin (RHO)-linked autosomal dominant retinitis pigmentosa (adRP) - a debilitating form of inherited blindness resulting from a diverse array of mutations in the RHO gene
www.genable.ie

Civitas Therapeutics

A privately held pharmaceutical company focused on developing products with a clinically proven dry powder pulmonary delivery platform.
www.civitastherapeutics.com

Cappella Inc

Medical device company developing a dedicated bifurcation stent for the treatment of complex coronary artery disease.
www.cappella-med.com

Palyon Medical Corporation

Medical device company developing programmable implantable pumps for delivery of therapeutics to the intrathecal space.
www.palyonmedical.com

Opsona Therapeutics

Drug development company focused on the role of Toll-Like Receptors (TLRs) and Inflammasome signalling in human immunology.
www.opsona.com

Amarin Corp

Biopharmaceutical company developing novel therapeutics for the treatment of cardiovascular and CNS disorders.
www.amarincorp.com

Vivasure Medical Ltd

Medical device company developing a closure device for vascular access procedures.
www.vivasuremedical.com